Trial Search Results
Use of PET/MR Imaging in Chronic Pain
The investigators are studying the ability of PET/MR imaging (using the PET tracer [18F]FDG) to objectively identify and characterize pain generators in patients suffering from chronic pain.
Stanford is currently accepting patients for this trial.
Collaborator: GE Healthcare
- Drug: [18F]FDG
- Device: PET/MRI
- Age 18 years or older.
- Clinically diagnosed chronic pain lasting greater than 2 months. Some example
diagnoses include (but not limited to): Low back pain, sciatica, complex regional pain
syndrome, post-traumatic pain, peripheral nerve injury, fibromyalgia, neuropathy,
osteoarthritis, cancer pain, persistent post-operative pain, traumatic brain injury,
pain from chronic cerebrospinal fluid leak, headache/migraine, chronic pruritus,
rheumatologic disease, neuropathy (diabetic-induced, Charcot-Marie-Tooth, CIDP), etc.
- Provides informed consent.
- On a typical day, the subject must have a minimum pain level of 4 on a 0-10
Comparative Pain Scale.
- Presence of MRI-incompatible materials/devices.
- Severe claustrophobia.
- Diagnosed psychiatric disorder that, in the opinion of the investigator, would impede
participation in the study.
- Pregnant or nursing.
- Severe comorbid conditions.
- Unable to read or complete questionnaires in English.
- Any other condition, which in the opinion of the investigator would impede compliance
or hinder completion of the study.
Ages Eligible for Study
18 Years - N/A
Genders Eligible for Study